NEWS On the Health Affairs Blog: Avorn Assesses the Landscape for Prescription Drug Regulation, Promotion, and Advocacy 3/23/17

In the latest post on the IVI-sponsored Health Affairs blog series, Jerry Avorn sums up the status quo in medical regulation and evidence-based prescribing. Avorn uses his commentary to call out flaws in the 21st Century Cures Act, illustrate how the appointment of a new FDA Commissioner may influence "right-to-try" laws, and discuss the promise of "academic detailing."

Read more here.